OSE Immunotherapeutics SA

OSE.PA | EURONEXT | 0 Sledující

€5.17

-2.91%

-€0.16

Sledovat

Overview Metrics Financials

Breakdown	12/31/2024 EUR	12/31/2023 EUR	12/31/2022 EUR	12/31/2021 EUR
Total revenue	69,877 +3,037.72%	2,227 -87.83%	18,302 -30.43%	26,306 -
Cost of revenue	69,877 -	0 -	0 -	0 -
Gross profit	0 -100.00%	2,227 -87.83%	18,302 -30.43%	26,306 -
Operating expense	33,446 +41.79%	23,589 -39.18%	38,782 -15.09%	45,673 -
Operating income	30,174 +231.27%	-22,986 +4.37%	-24,037 -9.39%	-21,973 -
Pretax Income	39,832 +271.53%	-23,221 +0.99%	-23,454 -8.79%	-21,558 -
Tax Provision	2,387 +1,189.95%	-219 +96.15%	-5,694 -20.94%	-4,708 -
Net income	37,445 +262.78%	-23,003 -29.52%	-17,760 -5.40%	-16,850 -
EPS	1.72 +245.76%	-1.18 -22.92%	-0.96 -3.23%	-0.93 -
Diluted EPS	1.48 +225.42%	-1.18 -22.92%	-0.96 -3.23%	-0.93 -
Average Shares	21,808 +11.48%	19,562 +5.99%	18,457 +1.67%	18,155 -
Diluted Average Shares	0 -100.00%	19,562 +5.99%	18,457 +1.67%	18,155 -
EBIT	45,427 +316.05%	-21,026 -26.28%	-16,650 -1.67%	-16,377 -
EBITDA	51,684 +395.32%	-17,501 -11.60%	-15,682 -7.01%	-14,655 -

Soubory cookie používáme ke zlepšení prohlížení na webu.